The prefilled syringes market is projected to register massive gain owing to the increasing prevalence of chronic diseases, rising preference towards plastic based prefilled syringes, increasing technological advancements in dual-chamber design, and high product adoption, mainly to overcome anaphylaxis.

A prefilled syringe is a single-dose vaccine packet with a fixed needle given by the manufacturer. Demand for these types of syringes is rapidly growing since it is considered the best choice for unit dose medication as the pharmaceutical industry seeks novel and more advanced drug delivery methods.

This growth has also impelled advancements in design, manufacturing, and prefilled syringe science. As a result, leading pharmaceutical firms can lessen wastage of drugs, thus increasing product life span, whereas patients are able to self-administer medications from the comfort of their homes rather than a hospital.

The prefilled syringes market is segmented into different sections in terms of type, design, application, and region.

Based on type, the prefilled syringes market is divided into plastic and glass. Among these, the plastic segment will witness a respectable CAGR of more than 13.4% over the analysis time period. This growth is attributed to the rising consumer preference towards plastic based prefilled syringes owing to its exceptional characteristics.

These types of prefilled syringes have high solvent and break resistance, wide range of pH, usually ranging from 2 to 12, and are easy and safe to use. In comparison to glass, plastic provides enhanced robustness and much better ergonomic feel. The two main plastic material used include Cyclo olefin co polymer and Cyclo olefin polymer.

With respect to design, the prefilled syringes market is classified into dual-chamber and single chamber. Among these, dual chamber segment will witness healthy growth through the forecast time period. In 2020, the segment held around 20% market share. The growth of this segment is ascribed to increasing technological advancements in dual-chamber along with novel attributes.

Dual-chamber prefilled syringes are very unique in their approach. These generally have two partitioned chambers, where the back chamber can be filled with its diluent and the front chamber with lyophilized drug product. In fact, both the front and back chambers can also be filled with drug products considered for co-delivery.

In terms of application, the overall market is categorized into antithrombotic/thrombolytic therapy, anaphylaxis, rheumatoid arthritis, diabetes, and others. In 2020, anaphylaxis segment accounted for more than $1 billion market value and is estimated to see strong growth over the coming time period. This is majorly ascribed to the increasing adoption of prefilled syringes among consumers to overcome anaphylaxis.

From a regional frame of reference, Latin America will witness around 12.5% CAGR over the forecast timeframe. This anticipated growth is accredited to increasing prevalence of chronic diseases across several countries of Latin America.